Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

Giovanni F.M. Strippoli, Allison Tong, David W. Johnson, Francesco Paolo Schena, Jonathan C. Craig

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

People with advanced kidney disease may be treated with peritoneal dialysis where a catheter is permanently inserted into the peritoneum (lining around abdominal contents) through the abdominal wall and sterile fluid is drained in and out a few times each day. The most common serious complication is infection of the peritoneum ‐ peritonitis. This may be caused by bacteria accidentally being transferred from the catheter. This review found that nasal mupirocin reduces exit‐site/tunnel infection but not peritonitis while preoperative intravenous antibiotic prophylaxis reduces early peritonitis but not exit‐site/tunnel infection. More large scale trials are needed.
Original languageEnglish
Article numberCD004679
JournalCochrane Database of Systematic Reviews
Volume2004
Issue number4
DOIs
Publication statusPublished - 18 Oct 2004
Externally publishedYes

Keywords

  • dialysis therapy
  • peritonitis
  • Antimicrobial agents

Fingerprint Dive into the research topics of 'Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients'. Together they form a unique fingerprint.

Cite this